Cannabix Technologies Participates in Southern U.S. Study Using Marijuana Breath Testing Technology in October, The Canadian Business Journal

VANCOUVER, British Columbia, OCTOBER 11, 2022 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (“Company or Cannabix”) announces marijuana breath detection for law enforcement and workplaces. I am a device developer. To test a supplemental version of the FAIMS technology for the detection of Δ9-tetrahydrocannabinol (“THC”) and related analytes in human breath in a comprehensive multi-analytical study of affected subjects, 10 I plan to participate in the research day in the middle of the month. Marijuana in the American South. Cannabix attended his two Test Day events in June and July in his two different cities in the United States. The October event will be held at a new location.in the Study of the Southern United States, Cannabix is ​​working with toxicologists and law enforcement officers who are testing subjects under the influence of marijuana. It has been used in parallel with several conventional drug screening methods involving fluid sampling. In addition, a closed-course driving test to measure disability is scheduled for study days in mid-October. Details of the study will be made available once approval for disclosure has been given to the company.

Data from previous studies have shown highly consistent correlations of THC levels in direct comparisons of exhaled breath samples collected and analyzed on Cannabix hardware to current whole blood standards. A new breakthrough method of drug detection that complements gold standard mass using our Handheld Breath Collection Unit (“BCU”, Figure 1) in conjunction with our newly developed laboratory “MS Breath Sampler” (Figure 2) provide. It greatly simplifies the analytical method (MS), reduces sample turnaround time (thus minimizing operating costs), and greatly simplifies analytical methods while maintaining sensitive and accurate results. increase.

The company has developed a unique breath capture system that can collect low volatility analytes such as THC from a sample size of only about 5 breaths. In addition, Cannabix devices efficiently capture analytes, completely eliminating the sample preparation steps required by traditional methods. The system detected and confirmed THC in his breath up to 4 hours after smoking, and breath samples were stored and analyzed up to 2 days after sample collection.

THC data in breath and blood

Cannabix has been an active participant in respiratory blood studies throughout the year and has completed trials in Ontario (see press release dated May 9).^th2022) and in parallel with law enforcement in the southern United States in June and July (see press release dated July 12)^th and August 25th^th, 2022). The study results show that his breath levels of THC over time are consistent across subjects, and the data show consistency of his THC levels between breath and whole blood at early time points after smoking. It shows the correlation that

Importance of research

By participating in these blood-respiratory correlation studies, the company will be able to collect a significant body of real-world respiratory data from a range of cannabis users, acquired using state-of-the-art hardware developed by Cannabis. building. These data greatly improve the accuracy of the recency of use with metabolic measurements. Blood is now the gold standard for drug decisions by law enforcement and toxicologists, and is used as objective evidence of possible harm in court.

According to the NHTSA Report to Congress (2017)¹ Blood THC drops rapidly when you stop using it. In contrast to alcohol, which is metabolized at a relatively steady rate, THC is metabolized at an exponentially decreasing rate, resulting in an initial rapid drop in blood levels of THC followed by low THC levels. Decrease slows down over time. Within 30 minutes of smoking, the amount of THC in blood and breath can drop by as much as 80-90% from peak levels. Low levels remain only for a few hours before returning to baseline levels. Because of this short window, confirming the presence of drugs as soon as possible after a law enforcement stoppage is paramount to providing accurate and objective evidence of the recency of cannabis use in drug driving. The Cannabix device allows immediate collection of exhaled breath samples in the event of suspected disability, significantly reducing the time required for the entire drug verification process. The analysis time (1–2 min per sample) is much shorter than most current methods, improving high-throughput operation and eliminating backlogs. Speed ​​up administrative procedures. Cannabix devices are easy to use and designed to work seamlessly with techniques toxicologists are already familiar with, requiring minimal training for all users.

The Cannabix tool provides rapid, non-invasive breath sample collection and easy analysis, with no sample preparation required. By comparison, existing and conventional breath and saliva testing procedures require several sample extraction and preparation steps prior to analysis, and the analysis itself can take 1-3 hours per sample. This is expensive and impractical. Also, existing and conventional breath and saliva testing procedures tend to be inefficient and time-consuming collection methods, and recovery rates remain poor. Cannabix has developed a unique approach to breath testing that reduces costs and makes operations and processes much more efficient.

^{(1) Marijuana Disabled Driving (nhtsa.gov)}

About Cannabis Technologies

Cannabix Technologies Inc. is a developer of marijuana breath detector technology for law enforcement and workplaces. Cannabix is ​​working on a drug screening device that uses breath samples to detect his THC, the psychoactive ingredient in marijuana that causes the disorder. A breath test for THC will allow employers and law enforcement to identify recent marijuana use and better match it to a disorder. The Cannabix device is in advanced prototype and preclinical testing stages.

We ask for safe harbor.
On behalf of the Board of Directors

“Love Marite”

CEO
Cannabix Technologies Inc.

Please contact us for more information. [email protected]gies.com

CSE has not checked and is not responsible for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information includes, but is not limited to, statements based on current expectations that involve a number of risks and uncertainties, including, but not limited to, final development, testing or piloting of commercial or prototype products. It is not a guarantee of our future performance, including the success of There is no guarantee that commercial sale of any kind of company technology will actually materialize. There is no guarantee that we will have sufficient funds to complete product development. There are a number of risks and uncertainties that could cause actual results and our plans and objectives to differ materially from those expressed in the forward-looking information. (ii) Risks Regarding Protection of Proprietary Technology. (iii) our ability to complete financing; (iv) our ability to develop and market future products; (v) risks related to government regulation, managing and sustaining growth, the impact of adverse press, litigation, competition and other factors that may be identified from time to time in our official announcements and filings; There is no guarantee that the development of marijuana breathalyzer technology will benefit the company, nor that the proposed new product will be built and successfully tested in beta or clinical trials. There is no guarantee that “pending” technology will receive patent status by regulatory agencies. We do not currently sell commercial breathalyzers. Actual results and future events could differ materially from those projected by such information. These and all subsequent written and oral forward-looking information are based on management’s estimates and opinions as of the date they were prepared and are expressly qualified in their entirety by this notice. We do not intend to update these forward-looking statements except as required by law.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3ba4b40b-fc02-41a7-b396-046315e38f91.

CBJ Newsmaker